If Dave was in control of anything he would have done his job properly and controlled the narrative. Instead, we have a clown whose greatest achievement is copying Biotech language verbatim, statistically significant data on... (speed, endurance, retention, yield).
Its not that hard, the goal has been and still apparently is an acquisition. He only needed to frame building a complete data set as a requirement for said acquisition, and thus until such point the company will further development and growth of said data set to gain maximum value.
With the success of the MB chip, pushing down to 20nm and a custom platform being created with Infineon, you could potentially put a positive spin on such developments. However, Dave's gross incompetence, extremely poor shareholder management and outright lies, only serve to highlight how out of his depth he truly is.
So now only the roseiest eyewear from the shop of Khoutam et al are able to see the positive spin in this sea of ineptitude, the rest of us are just holding on because when the ship is 90% down, it serves no point jumping here. Any decent bid on the share price will likely see a 4th or 5th generation of investors get fed up and leave this s&*t show.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)